ClinicalTrials.gg
Drug

Rabeprazole clinical trials

Also written Aciphex, Pariet and E3810.

studies test it
105
open now
3
in phase 3
26
first study started
2001

How each study uses Rabeprazole is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Rabeprazole studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
19 Aug 1999 · ACIPHEX · NDA 020973 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Rabeprazole
35
Rabeprazole sodium
18
Rabeprazole 20 mg
3
Rabeprazole Sodium 20mg
3
Idiazole 20mg DR tabs
3

Brand

Aciphex
9
Pariet
8

Development codes

E3810
2

In one entry with another drug

Given together, or one or the other

E3810
4

Studies by the year they started

102 studies that test it; most in 2005 (10)

Studies that test Rabeprazole, by start year
YearStudies
20011
20022
20035
20046
200510
20065
20073
20089
20096
20109
20117
20122
20136
20144
20152
20164
20172
20182
20192
20201
20213
20223
20232
20242
20251
20263

By phase

A phase 1/2 study counts in both.

Phase 1
34
Phase 2
14
Phase 3
26
Phase 4
25
No phase
12

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 64 · Other 41

Eisai Inc. (12) · Eisai Co., Ltd. (9) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (6) · Pfizer (4) · GlaxoSmithKline (3) · The Catholic University of Korea (3) · Lomond Therapeutics Holdings, Inc. (2) · Genentech, Inc. (2)

Often tested with

Tested in the same studies.

Amoxicillin (10) · Clarithromycin (8) · Itraconazole (4) · E-3810 (4) · Metronidazole (4) · Famotidine (3) · Palbociclib (3) · Pantoprazole (3)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 1 phase 3 study under way

Rabeprazole is the comparator. A study of two new drugs counts under both.

Reaching primary completion within a year · 1

Studies that test Rabeprazole.

Studies

Open first, then newest update. How each study uses Rabeprazole is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 105

See all 105 studies that test Rabeprazole →

Given beside what is tested · 44 — Rabeprazole is usual care or a partner of the new treatment

Showing 20 of 44.

As the comparator · 13 — what is tested is compared with Rabeprazole

Codes

What other systems call Rabeprazole · ClinicalTrials.gg INT008978

  • MeSH (NLM) D064750RabeprazoleConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 32828355LLRABEPRAZOLEConfirmed FDA, NLM, Wikidata
  • RxNorm 114979Confirmed FDA, Wikidata
  • Wikidata Q3515(RS)-rabeprazoleConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C29410RabeprazoleOne source FDA
  • DrugBank DB01129One source Wikidata

Also registered as dexrabeprazole (UNII 65JK8810RM) and rabeprazole sodium (UNII 3L36P16U4R · RxNorm 226868).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.